Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

ElleS vs EmbraceRX

ElleS
Graded #423

Lower grade

vs+2.6000000000000014
EmbraceRX
Graded #363

Higher grade

The verdict

EmbraceRX takes it — 58.6/100 to 56/100.

EmbraceRX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. EmbraceRX (Embrace Rx) is a clinician-guided telehealth platform offering pharmacy-compounded medications prescribed online, partnered with the Samaritan MD physician network.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
45
45
Dose & formulationEmbraceRX +5
51
56
Clinical oversightElleS +2
78
76
Labs & monitoringElleS +9
61
52
FulfillmentEmbraceRX +5
68
73
Contract termsEmbraceRX +35
20
55
ElleS · left barEmbraceRX · right bar

The numbers

MetricElleSEmbraceRX
WeighScore56/10058.6/100
GradeCC
Scorecard rank#423#363
SemaglutideNot disclosedNot disclosed
TirzepatideNot disclosedNot disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesYes
ElleS

Graded #423 · C

Strengths

  • Compounded semaglutide and tirzepatide in both injectable and oral-capsule forms, plus microdose options
  • Packages bundle the telehealth visit, medication, and shipping; Registered Dietitian support included
  • Full legal suite published — Terms, Privacy Policy, Privacy Practices, and Medical Consent
  • Broad menu: also TRT, HRT (estradiol), sexual health, hair loss, and longevity (sermorelin, NAD+)

Where it loses points

  • Pricing not shown publicly — products and costs appear only after the intake flow
  • Sold as 3- and 6-month packages rather than simple monthly plans
  • Compounding pharmacy partner not named ('made in licensed US facilities')
  • Not LegitScript-certified (no certification displayed)
EmbraceRX

Graded #363 · C

Strengths

  • Broad compounded GLP-1 menu — semaglutide (+B12), tirzepatide, oral semaglutide/tirzepatide capsules, plus Lipo-B
  • Large peptide/longevity catalog (BPC-157, GHK-Cu, NAD+, MOTS-C) across injectable, oral, topical, and nasal formats
  • Clinician-guided, compounded at FDA-registered pharmacies; partners with a licensed physician network (Samaritan MD)
  • Full legal suite published (Terms, Privacy, HIPAA Notice, CCPA, Returns & Refunds)

Where it loses points

  • Pricing not shown upfront — revealed only at checkout after a dose selection
  • Offers investigational/research compounds (e.g., retatrutide, AOD-9604) that are not FDA-approved
  • Compounding pharmacy partner not named ('FDA-registered pharmacies')
  • Not LegitScript-certified (no certification displayed)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard